Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥1.2bn2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥1.5bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Operating income¥315m2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income¥294m2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥136m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Profit before tax¥343m2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥226m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥162m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income¥226m2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥1.2bnat 2022-06-30Cons.Assets
Total assets¥664mat 2021-12-31Cons.Assets
Total liabilities¥565mat 2022-06-30Cons.Liabilities
Total liabilities¥416mat 2021-12-31Cons.Liabilities
Net assets / equity¥616mat 2022-06-30Cons.Net assets
Net assets / equity¥247mat 2021-12-31Cons.Net assets
Cash and deposits¥829mat 2022-06-30Cons.Cash and deposits
Cash and deposits¥423mat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥829mat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥423mat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥285m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥202m2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥25m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥21m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥146m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥53m2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥23.342022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.592022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.122021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥21.722022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio52.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio37.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-06-30¥100m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-06-30¥100m
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥125m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥125m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥25m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥54m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥30m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥24m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥558,000
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥435m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥435m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥244m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥715m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥715m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥500,000
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥97m
—segment totalrevenue2022-01-01 → 2022-06-30¥1.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥1.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥340m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-01-01 → 2022-06-30¥125m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30¥340m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 375
ItemContextValueUnit
Listing expenses ope cfCurrentYTDDuration16805000JPY
Share acquisition rights issuance costs ope cfCurrentYTDDuration2040000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-58023000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-105000JPY
Decrease increase in prepaid expenses ope cfCurrentYTDDuration307000JPY
Decrease increase in long term prepaid expenses ope cfCurrentYTDDuration370000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration19772000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-1253000JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration-3509000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration4735000JPY
Other net ope cfCurrentYTDDuration4881000JPY
Subtotal ope cfCurrentYTDDuration293691000JPY
Interest income received ope cfCurrentYTDDuration1000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-1316000JPY
Settlement package paid ope cfCurrentYTDDuration-1000000JPY
Income taxes paid refund ope cfCurrentYTDDuration-6545000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration284830000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-1958000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-22886000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-24844000JPY
Proceeds from long term borrowings fin cfCurrentYTDDuration100000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-71225000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration135924000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-6420000JPY
Payment of listing expenses fin cfCurrentYTDDuration-10898000JPY
Payments from issuance of share acquisition rights fin cfCurrentYTDDuration-1563000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration145817000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration405802000JPY
Cash and cash equivalentsPrior1YearInstant423499000JPY
Cash and cash equivalentsCurrentQuarterInstant829302000JPY
Salaries and allowances sgaCurrentYTDDuration131049000JPY
Expenses for recruiting doctors and others sgaCurrentYTDDuration125240000JPY
Advertising expenses sgaCurrentYTDDuration43622000JPY
Legal welfare expenses sgaCurrentYTDDuration20006000JPY
Directors compensations sgaCurrentYTDDuration18876000JPY
Commission fee sgaCurrentYTDDuration18202000JPY
Recruiting expenses sgaCurrentYTDDuration14912000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E37508-000MentalHealthSolutionBusinessReportableSegmentsMember714595000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E37508-000MedicalCareerSupportBusinessReportableSegmentsMember434931000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E37508-000DigitalMarketingBusinessReportableSegmentsMember30215000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember1179742000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1179742000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration1179742000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E37508-000MentalHealthSolutionBusinessReportableSegmentsMember500000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E37508-000MedicalCareerSupportBusinessReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E37508-000DigitalMarketingBusinessReportableSegmentsMember23611000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember24111000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 11 of 11 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass